Bolt Biotherapeutics Inc.

0.40
0.02 (4.44%)
At close: Apr 02, 2025, 3:57 PM
0.39
-2.50%
After-hours: Apr 02, 2025, 06:35 PM EDT

Bolt Biotherapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Revenue 7.69M 7.88M 5.73M 1.26M 231K 215K n/a
Cost of Revenue n/a 1.88M 4.89M 3.67M 40.36M 26M 302K
Gross Profit 7.69M 5.99M 838K -2.41M -40.13M -25.79M -302K
Operating Income -73.05M -76.2M -90.32M -92.79M -49.18M -30.97M -11.63M
Interest Income 5.25M 7M 2.22M 281K 199K 524K 193K
Pretax Income -63.12M -69.2M -88.1M -98.59M -60.73M -30.49M -11.59M
Net Income -63.12M -69.2M -85.88M -104.39M -72.27M -30M -11.59M
Selling & General & Admin 18.46M 22.53M 22.93M 18.39M 9.06M 5.18M 2.21M
Research & Development 57.47M 61.54M 73.12M 75.66M 40.36M 26M 9.42M
Other Expenses 4.81M n/a n/a -6.08M -11.74M -42K -153K
Operating Expenses 80.74M 84.07M 96.05M 94.05M 49.41M 31.18M 11.63M
Interest Expense n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 80.74M 84.07M 96.05M 94.05M 49.41M 31.18M 11.63M
Income Tax n/a n/a -2.22M 5.8M 11.55M -482K 40K
Shares Outstanding (Basic) 38.18M 37.81M 37.36M 37.4M 36.25M 35.1M 9.42M
Shares Outstanding (Diluted) 38.18M 37.81M 37.36M 37.4M 36.25M 35.1M 9.42M
EPS (Basic) -1.65 -1.83 -2.3 -2.79 -1.99 -0.85 -1.23
EPS (Diluted) -1.65 -1.83 -2.3 -2.79 -1.99 -0.85 -1.23
EBITDA -66.45M -74.34M -88.66M -91.59M -48.57M -30.63M -11.33M
EBIT -68.24M -76.2M -90.32M -92.79M -49.18M -30.97M -11.59M
Depreciation & Amortization 1.78M 1.85M 4.89M 3.67M 2.5M 1.33M 302K